Results for tag: "Batroxobin"

Batroxobin is a hematological drug derived from the venom of the South American pit viper, Bothrops atrox. It is used to treat a variety of conditions, including bleeding disorders, thrombocytopenia, and hemophilia. It is also used to reduce the risk of blood clots in patients undergoing surgery. Batroxobin works by inhibiting the activity of Factor Xa, a protein involved in the clotting process. Batroxobin is available in both injectable and oral forms. The injectable form is used to treat acute bleeding episodes, while the oral form is used for long-term prophylaxis. The drug is approved for use in many countries, including the United States, Canada, and the European Union. The batroxobin market is highly competitive, with several companies offering products. These include CSL Behring, Grifols, Novo Nordisk, Pfizer, and Shire. Each company offers a range of products, including both injectable and oral forms. Show Less Read more